Analgesia, Anesthetic Agents, And Special Techniques Flashcards

(46 cards)

1
Q

Agonist

A

Bind and stimulate receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Partial Agonist

A

Bind and partially stimulate receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Agonist-antagonist

A

Stimulate one receptor and blocks another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antagonist

A

Bind partially to a stimulator blocking effects of agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List anesthetics and adjuncts that can be reversed

A

Flumazenil-> benzodiazepines (uncommon to use)
Alpha-2 Antagonist (Atipamezole, Yohimbine)-> short DoA (redoes); avoid when anticholinergics given
Naloxone, Butorphanol-> Opioid -> given as emergency/revive neonates; rare adverse effect (correct dose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dose dependent

A

Magnitude of effect (adverse, desired) of anesthesia and adjunct is based on dose given

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Preanesthetic:
Anticholinergics/Parasympatholitics (Atropine, Glycopyrrolate)

A

Indication: minimize bradycardia, respiratory, salivary, GI, lacrimal secretion; bronchodilator
MoA: block acetylcholine receptors
Route: SQ, IM (common), IV, IT (emergency)
Onset: 1-5 min, peak 5-20 min
DoA: 60-90 min (Atropine), 2-3 hrs (Glyco)
AE: tachycardia, arrhythmia, mydriasis, inhibit intestinal peristaltis = colic, bloat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Preanesthetic:
Phenothiazine (Acepromazine)

A

Indication: sedation/calming, reduce seizure threshold, anti-arrhythmic, antiemetic, antihistamine
MoA: Depress reticular activating center of brain; metabolized by liveth, cross placenta
Route: IM (dogs), IV (horse)
Onset: 15 min, peak 30-60 min
DoA: 4-8 hours (SA), 1-3 (LA)
AE: tachycardia/bradycardia, hypotension, decreased PCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Preanesthetic:
Benzodiazepine (Diazepam/Valium, Midazolam) Class IV

A

Indication: anti-anxiety/calming, anticonvulsant, skeletal muscle relaxant
MoA: increase activity of Gaba = depressing CNS
Route: IV, IM (Midazolam only)
Onset: 15 min
DoA: 1-4 hr
AE: Disorientation/excitement (dogs), dysphoria/aggression (cats), pain IM site, ataxia (LA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Preanesthetic:
Alpha-2 Agonist (Dexmedetomine, Xylazine)

A

Indication: Sedation, Analgesia, Muscle relaxant
MoA: Stimulate receptor of SNS ↓ release of norepinephrine, metabolized by liver, excreted urine
Route: IV, IM
Onset: 5-15min (IV), 15-30(IM) DoA: 1-4hr
AE: Aggitation/aggression, hypertension/bradycardia hypotension, respiratory depression, vomiting, hyperglycemia, hypothermia, polyuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Preanesthetic:
Opioids

A

Indication: analgesia, sedation/CNS depression
MoA: bind/partially bind/displaces µ, κ receptors
Route: IV, IM, SQ, rectal, oral, transdermal, local
Onset: varies
DoA: most <30 min
AE: CNS stimulation/dysphoria (cats), bradycardia/respiratory depression, panting, hypothermia (dogs), hyperthermia (cats), V/D, ileus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Preanesthetic:
Neuroleptanalgesia

A

Indication: Opioid & Tranquilizier (acepromazine, alpha2agonist, benzodiazepine) for profund analgesia & sedation used for debilitated dogs minor procedure
Route: IM, slow IV
AE: Can cause excitement in cats, mania in young dogs; bradycardia fast infusion (intubate & assist ventilation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Preanesthetic:
Propofol

A

Indication: Sedation/short-term GA*, muscle relaxation, antiemetic, ↓ intracranial & ocular pressure
MoA: ↑ action of GABA to depress CNS
Route: IV CRI or repeat boluses (over 1-2min, q 3-5)
Onset: 30-60sec
DoA: 2-5min, recover 20-30min
AE: Tansient excitement/tremor (induction), bradycardia, ↓ cardiac output, hypotension, respiratory depression/apnea (rapid injection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Injectable Anesthesia:
Alfaxalone

A

Indication: Sedation/short-term GA*, muscle relaxation, minimal cardiovascular depression
MoA: Bind to GABA receptors (similar to Propofol)
Route: IV, IM (cats)
Onset: varies
DoA: most <30min
AE: Tachycardia, hypotension (+inhalant), respiratory depression/apnea (rapid IV), excitement (recovery)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain the effect of protein binding, lipid solubility, and redistribution on the pharmacokinetics and pharmacodynamics of injectable anesthetics.

A

Propofol macroemulsion large particles scatter light (cloudy/milky) from milk fat, glycerin, oil
• Lipid soluble = 1-5% unbonded passes through brain (more potent if hypoproteinemic)
• 95-99% bounded to plasma proteins
• Diffuses heart, kidney, liver (rich in vessels) → muscle → fat once blood concentrate ↓
• Metabolized by liver, excreted by urine (1-2hrs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Injectable Anesthetic:
Barbiturates (not commonly used)
Class III

A

Indication: GA for lab animals, epilepticus/intractable seizures, euthanasia solution
Use as IV injectable replaced by propofol, alfaxalone & inhalants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Injectable Anesthesia:
Dissociative
Ketamine, Benzodiazepine, Ketamine+Diazepam/Midazolam
Class III

A

Indication: Catelepsy (unresponsive, muscle rigidity), somatic analgesia
MoA: Inhibit NMDA receptors = prevent windup
Route: SQ, IV, IM
Onset: 1-2min IV, 10min IM DoA: 20-30min
AE: intact reflexes, stimuli sensitivity, nystagmus (cats), apneustic respiration, ↑ HR, cardiac output, MAP, intracranial & ocular pressure, tissue irritation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Nitrous Oxide (N2O)

A

Indication: Speeds induction & recovery, additional analgesia (with added agents), MAC reducing = reduces cardiopulmonary & respiratory AE
Seldom use as Iso & Sevo already produce rapid induction & recoveries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Define vapor pressure and how this property affects action and use of inhalants.

A

Amount of pressure excreted by gaseous form of substance when gas & liquid is in equilibrium

Tendency to evaporate in vaporizer – based on agent & room temperature

Available inhalants are volatite (evaporates readily) so uses agent specific precision vaporizer*

*Isoflurane stored in nonprecision Stevens vaporizer specifically made for it

20
Q

Define partion coefficient (BGPC) and how this property affects action and use of inhalants.

A

Solubility of inhalant anesthetic in blood compared to alveolar gas

Inhalants ↓ BGPC = faster induction, response to change in vaporizer setting, recovery
↑ BGPC = highly soluble in blood & tissue

21
Q

Define minimum alveolar concentration (MAC) and how this property affects action and use of inhalants.

A

Average setting used to produced anesthesia
(↓ MAC = more potent)

Estimated vaporizer setting: 1x MAC = light stage III
1.5 x MAC = surgical anesthesia
(Iso Maintainenance ~1.5-2.5% Sevo ~2.5-4%)
*Setting based on age, metabolic activity, body temperature, patient condition (dz, obese, pregnant)

22
Q

Inhalant Anesthetic:
Isoflurane, Sevoflurane, Desflurane

A
  1. Isoflurane: most common induction/maintenance
    VP: 240mmHg
    BGPC: 1.46
    MAC: 1.3-1.63
  2. Sevoflurane: less irritating, minimal odor, costly
    VP: 160mmHg
    BGPC: 0.68
    MAC: 2.3-2.5
  3. Desflurane: pungent, induce breath holding, sympathethic storm (transient ↑ HR, BP – humans)
    VP: 700mmHg
    BGPC: 0.42
    MAC: 7.2-9.8
    - special vaporizer to prevent boiling
    - ‘one breath anesthesia’, least potent
23
Q

Describe the uptake, distribution, and elimination of the commonly used inhalation anesthetic agents.

A

MoA of inhalants: Unknown, may inhibit nerve cell function in brain & spinal cord

Uptake of inhalants: Fresh gas diffuse in alveolar membrane → blood based

Distribution: Induce – diffuse in vascularized organs (↑ alveoli ↓ blood), enter brain, diffuse back to alveoli when vaporizer discontinued (↑ blood ↓ alveoli)

Eliminated by lungs, minimal liver metabolism

24
Q

Analeptic (CNS Stimulant):
Doxapram

A

Indication: Induce respiration, recovery in emergency, reverse effects of inhalants & barbiturates

Route: IV, PO/sublingual/umbilical vein - neonates
Onset: 2 minutes (IV)

AE: Wide margin of safety; hyperventilation, hypertension, arrhythmia, lowers seizure threshold, can cause CNS damage (provide O2 support)

25
List the advantages and disadvantages associated with the use of local anesthetic agents.
Low cardiovascular/respiratory toxicity, inexpensive, analgesia, doesn’t cross placenta, minimal recovery Common in LA (standing sedation) but used in conjuncton with GA for SA, no reversal, cause arrhythmia, myocardial depression (overdose)
26
Lidocaine 2% Bupivacaine 0.5%
MoA: Blocks sodium channels so sensory & motor neurons cannot depolarize Onset: 1-5min (L), 10-20min (B) DoA: 1-2hr (L), 4-6h (B) Add epinephrine to Lidocaine to prolong DoA
27
Explain the risks involved and the adverse effects that may be seen with the use of local anesthetic agents.
- Affect motor neurons (CNS to periphery) = paresis (weakness) & paralysis (loss of voluntarily movement) - Paresthesia: ‘tingling’ sensation - Allergic reaction – hives, anaphylaxis - Tissue irritant, loss of function (direct nerve inj) - Systemic toxicity (IV w/out torniquet, large SQ) - Sympathethic blockade (loss of sensation to SNS) – vasodilation/hypotension, hypertension
28
Use of local anesthesia: Topical
EMLA cream (Lidocaine + Prilocaine) – for IV catheter placement, occlusive dressing; not to be applied eyes, broken skin/accessible to patient Splash block: place in open wound – spray, gauzed with anesthetic & saline
29
Use of local anesthesia: Infiltration
Inject under aseptic skin & in proximity of a nerve for analgesia & anesthesia to area (for skin biopsy, mass removal, minor lacerations) – onset 3-5min Ineffective – deep tissue (muscle), scar/fibrous or inflamed tissue
30
Use of local anesthesia: Outline the methods for performing a nerve block and a line block, and list clinical situations in veterinary practice un which these blocks are used.
Inject in close proximity of nerve – dental, intercostal (chest) Line block – continuous line in SQ/ID proximal to target area (horse, cattle) Ring block – block an encircled area (digit)
31
Use of local anesthesia: Intraarticular
Inject (diluted Bupivacaine) into stifle joint
32
Use of local anesthesia: Regional
Inject into major nerve plexus/in proximity to spinal cord - blocks nerve impulse to & from large area Paravertebral – T13 to L2 (C-section) Epidural IV (Bier Block) <1hr local anesthesia to extremity (amputation)
33
Use of local anesthesia: Epidural
Epidural block sensation in abdomen, pelvis, tail – temporary immobility, analgesia (tail amputation), debilitated animals (cannot tolerate GA) Insert needle perpendicular within spinal canal
34
Explain the difference between assisted and controlled ventilation
Assisted Ventilation: ↑ amount of gas delivery (fresh gas), patient initiate inhalation Controlled Ventilation: deliver all air patient require, patient does not make spontaneous respiratory efforts Positive pressure ventilation (PPV): assisted and control ventilation - delivering of oxygen & anesthetic gas to patient's lung; evaluated w/ SPO2 & ETCO2
35
Ventilation in awake vs. anesthetized animal
- Ventilation – movement of air in & out lung - Active phase (inhalantion) - triggered by respiratory center in the brain & ↑ PACO2 >40mmHg, intercostal muscle push ribcage outward, diaphragm flatten - Passive phase (exhalation) - relaxation of diaphragm & intercostal muscle ↑ PACO2 triggering another inspiration, 2x longer - Anesthetics ↓ responsiveness of respiratory center to CO2 (less inhalation), relax intercostal & diaphragm (↓ VT, RR, RMV)
36
Describe the techniques of manual (periodic, intermittent) ventilation and their application to anesthesia.
Manual ventilation lungs filled O2 from ↑ pressure entering lungs as reservoir bag is squeezed, passive exhalation Periodic bagging (1-2 breaths q 2-10min): close popoff valve, compress RV ≤20 cm H2O Intermittent ventilation (bagging throughout procedure): close pop off valve, open every 2-3 breaths
37
Describe the techniques of mechanical ventilation and their application to anesthesia.
Ventilator provides intermittent ventilation – for thoracotomy/lengthy operations/LA Patient intubated, monitor vitals & anesthestic depth Risk of controlled ventilation – excess airway = ruptured aleveoli, ↓ cardiac output, hyperventilation, excess anesthetic depth
38
List the indications for the use of neuromuscular blocking agents and the hazards associated with their use.
Skleletal muscle paralyzing agents – mechanical ventilation (prevents spontaneous inspiration), orthopedic, opthalmic, C section Always administer patient unconcious, give slow IV/CRI, ↑ inhalant potency Can make assessing depth difficult (depress blink reflex), hypothermia (↓ muscle tone)
39
Describe the differences between the 2 classes of neuromuscular blocking agents, including mode of action and reversibility.
MoA: interrupt normal transmission of impulses from motor neurons Depolorazing agents – muscle twitch & paralysis Onset: 20 sec, short DoA AE: Hyperkalemia, cardiac arrhythmia Nondepolarizing – blocks receptors AE: histamine release, hypo/hypertension, tachycardia
40
Pure µ agonist opioid: Morphine, Hydromorphone, Methadone, Fentanyl (Class II)
Indication: Analgesia (moderate to severe), Sedation/CNS depression MoA: Bind μ receptors Route: IV, IM, SQ, Epidural/Regional Onset: varies DoA: most <30min AE: bradycardia/respiratory depression, panting, hypersensitivity, vomiting (less likely Methadone), CNS hypersensitivity (Methadone)
41
Pure µ agonist opioid: Buprenorphine (Class III)
Indication: Analgesia (mild/moderate), prolonged sedation MoA: Bind μ receptors - less potent Route: IV, IM, SQ, Epidural/Regional, Oral (cats) Onset: 15min IV DoA: 6-12hr IM AE: respiratory depression – reversed with Doxapram
42
µ Agonist-antagonist Opioid: Butorphanol (Class III)
Indication: Analgesia (mild/moderate visceral pain), reverse respiratory depression/sedation of μ agonist MoA: Blocks μ, stimulate κ receptors Route: IV, IM, SQ DoA: 1hr IM AE: high dose – respiratory depression (ceiling effect), hypotension, bradycardia, panting, vomiting, histamine release
43
Describe the uses for and procedure for application of fentanyl transdermal patch.
For use in post op patient (orthopedic, abdominal), trauma, cancer Sized patch has Fentanyl reservoir enclosed in plastic applied to aseptic & clip skin
44
Mechanism of action, use, and adverse effects of NSAIDs
Indication: Analgesia (all somatic, some visceral), anti-inflammatory, antipyretic MoA: Inhibit synthesis of prostaglandin (involved in pain & inflammation) by inactivating COX enzyme Route: Oral, injectable Onset: 30-60min DoA: varies by species AE: liver damage, GI ulceration, renal toxicity, impaired platelet aggregation
45
List other analgesic agents
- Tramadol: at home analgesia (activity µ) - Tranquilizers potentiate effect of opioids - Gabapentin – neuropathic & allodynia - Amantadine – analgesic adjunct for neuropathic pain - Corticosteroids – anti-inflammatory - Antidepressants/anti-anxiety - combined for neurogenic (cancer pain) - Alpha2 agonist (short term) - Dissociative (prevents windup)
46
Describe nursing care that relieves discomfort in hospitalized patients.
- Padded, clean, kennel - Quiet area - Avoid putting cats in bottom row cages - Respositioning, eye drops - Gentle handling & owner visitins - Nutritional intervention